MedTrace Logo

A Clinical Trial Study of Hip System in Primary Total Hip Arthroplasty in China

NCT02399007 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2018-04-04

No results posted yet for this study

Summary

A clinical trial of total Hip system used in Primary Total Hip Arthroplasty in China.

Conditions

Interventions

DEVICE

Total Hip System made in China (SUN, CoCr, Duraloc, Marathon)

SUN Hip stem,CoCr Femoral Head,Duraloc Porocoat Sector acetabular shell,Marathon 10D polyethylene liner (ETO)

DEVICE

Total Hip System made outside of China (Summit, CoCr, Duraloc, Marathon)

Summit Porocoat STD,CoCr Femoral Head,Duraloc Porocoat Sector acetabular shell,Marathon 10D polyethylene liner (ETO)

Sponsors & Collaborators

  • Johnson & Johnson Medical (Suzhou) Ltd.

    lead INDUSTRY

Principal Investigators

  • Shigui Yan · The second Affiliated Hospital of Zhejiang Medicine University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
55 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-07
Primary Completion
2017-12-04
Completion
2018-01-17

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02399007 on ClinicalTrials.gov